Antidepressants and the Elderly
- 1 December 1986
- journal article
- review article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 34 (12) , 869-874
- https://doi.org/10.1111/j.1532-5415.1986.tb07261.x
Abstract
The pharmacologic treatment of depression in the elderly is often complicated by cardiovascular disease and other medical illnesses. Both the tricyclic antidepressants and the monoamine oxidase (MAO) inhibitors have adverse effects that are potentially dangerous in this age group. Second generation antidepressants may have fewer cardiovascular and anticholinergic side effects, but many do not offer any real advantage over the older drugs. In practical terms, the choice of antidepressants for use in elderly patients will be based largely on their degree of tolerance for unwanted effects.Keywords
This publication has 47 references indexed in Scilit:
- Second Generation Antidepressants: A Comparative ReviewThe Journal of Clinical Pharmacology, 1985
- First results on the effects of MAO inhibition on cognitive functioning in elderly depressed patientsArchives of Gerontology and Geriatrics, 1983
- Trazodone exacerbation of VTAmerican Heart Journal, 1983
- Premature Atrial Contractions and Amoxapine TherapyJournal of Clinical Psychopharmacology, 1983
- AmoxapineDrugs, 1982
- The Side Effect Profile of Trazodone in Comparison to an Active Control and PlaceboJournal of Clinical Psychopharmacology, 1981
- Effects of Acute Administration of Trazodone and Amitriptyline on Cognition, Cardiovascular Function, and Salivation in the Normal Geriatric SubjectJournal of Clinical Psychopharmacology, 1981
- MaprotilineDrugs, 1977
- Pharmacokinetics in the ElderlyClinical Pharmacokinetics, 1976
- The Natural History of Mental Disorder in Old AgeJournal of Mental Science, 1955